Tag Archives: Valsartan

[ad_1] ScieGen's angiotensin II receptor blocker (ARB) is a carcinogenic protein that has been detected during the testing, and the FDA warned in a MedWatch Safety Alert. Westminster Pharmaceuticals and Golden State …

[ad_1] A photo of a man who has his blood pressure tested. The FDA has found NDEA, another known carcinogen, in some lots of valsartan medications used to treat heart problems and …

[ad_1] The US Food and Drug Administration found a second carcinogenic impurity in three batches of valsartan, a popular blood pressure medication. The lots were all sold through Torrent Pharmaceuticals. The discovery …

[ad_1] Friday, September 14, 2018 (HealthDay News) – There is more bad news for Americans who have taken some brands of the common drug for blood pressure, valsartan. The US Food and …

[ad_1] Highlights of the story Tests of some drugs containing valsartan revealed another impurity The NDEA impurity is also a carcinogen Several pills containing valsartan, a generic ingredient that helps people with …

[ad_1] Some drugs containing valsartan, a blood pressure medication, may contain a second substance that can cause cancer, according to Health Canada. All drugs containing valsartan, manufactured by Zhejiang Huahai Pharmaceuticals in …

[ad_1] Now, an accelerated study suggests that there is no significantly increased risk of short-term global cancer in users of valsartan contaminated with impurity, N-nitrosodimethylamine or NDMA. However, additional research is needed …

[ad_1] Three companies that repackage drugs withdraw drugs containing valsartan, and others should follow the same path, according to the United States Food and Drug Administration (FDA). Products containing valsartan manufactured by …

[ad_1] This impurity, N-nitrosodimethylamine or NDMA, is classified as possibly carcinogenic to humans, based on laboratory test results. Valsartan is a non-patent medicine, but not all drugs containing "Our drug shortage team …